Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.40    0.20 (0.19%)
Bid:
102.80
Ask:
103.60
Spread: 0.80 (0.778%)
Market Cap: £169.52m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Directorate Change

21 Sep 2018 09:17

RNS Number : 5308B
Synthomer PLC
21 September 2018
Β 

LEI: 213800EHT3TI1KPQQJ56

Β 

21 September 2018

Synthomer plc

Appointment of Non-Executive Director

Synthomer plc ('Synthomer' or 'the Company') today announces that it has appointed Holly Van Deursen as a Non-Executive Director. Holly will join the Board with immediate effect.

Holly has worked in the global chemicals industry for over 25 years, with senior positions across North America, Europe and Asia. She joined Dow Corning Corporation, a joint venture between the Dow Chemical Company and Corning Incorporated, in 1981 with roles in Process Engineering, Manufacturing and Product Development. In 1989 she moved to AMOCO, the global chemical and oil Company, where she worked across a number of different areas in the US, Hong Kong and the UK. She then spent 4 years at BP from 2001, latterly as Group Vice President, Petrochemicals.

In addition, Holly has 11 years' experience as a Non-Executive Director in the USA. . She currently sits on the Board at Bemis Company (NYSE:BMS), Capstone Turbine Corporation (NASDAQ:CPST) and Actuant Corporation (NYSE:ATU). Holly was also on the board of Petroleum Geo Services (OSE) until earlier this year after serving for 12 years.

Holly has a Chemical Engineering Degree from the University of Kansas and an MBA from the University of Michigan.

Neil Johnson, Chairman, said:

"I am delighted to welcome Holly to Synthomer's Board. She brings a wealth of sectoral and global business experience that will be invaluable as we continue to develop the Group and strengthen our platform for future growth. We look forward to working with her. "

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

-ENDS-

Enquiries:

Synthomer plcNeil Johnson, Chairman

Β 

+44 (0) 12 7943 6211

Teneo Charles Armitstead

Β 

+44 (0) 20 3603 5220

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAUAAWRWVAKURR
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.